Campylobacter jejuni subsp. jejuni (Jones et al.) Veron and Chatelain
商品貨號(hào)
B223552
Strain Designations
INP59
Application
Emerging infectious disease research
Enteric Research
Isolation
Patient with Guillain-Barre Syndrome, Mexico
By I Nachamkin and P Azarte, 1998
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Antigenic Properties
Serotype HS:41
Product Format
freeze-dried
Preceptrol®
no
Type Strain
no
Medium
ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 37°C
Atmosphere: Microaerophilic (10% CO2, 3-5% O2)
Name of Depositor
I Nachamkin
Year of Origin
1998
References
Nachamkin I, et al. Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barre syndrome and gastroenteritis.. J. Infect. Dis. 184: 221-226, 2001. PubMed: 11400077
Engberg J, et al. Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barre syndrome and gastroenteritis.. J. Infect. Dis. 184: 215-220, 2001. PubMed: 11400076
